Active Ingredient History

  • Now
Vidarabine or 9-β-D-arabinofuranosyladenine (ara-A, trade name Vira-A) is a synthetic purine nucleoside analog with in vitro and in vivo inhibitory activity against herpes simplex virus types 1 (HSV-1), 2 (HSV-2), and varicella-zoster virus (VZV). The inhibitory activity of Vidarabine is highly selective due to its affinity for the enzyme thymidine kinase (TK) encoded by HSV and VZV. This viral enzyme converts Vidarabine into Vidarabine monophosphate, a nucleotide analog. The monophosphate is further converted into diphosphate by cellular guanylate kinase and into triphosphate by a number of cellular enzymes. in vitro, Vidarabine triphosphate stops replication of herpes viral DNA. When used as a substrate for viral DNA polymerase, Vidarabine triphosphate competitively inhibits dATP leading to the formation of 'faulty' DNA. This is where Vidarabine triphosphate is incorporated into the DNA strand replacing many of the adenosine bases. This results in the prevention of DNA synthesis, as phosphodiester bridges can longer to be built, destabilizing the strand.   NCATS

  • SMILES: NC1=NC=NC2=C1N=CN2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O
  • Mol. Mass: 267.2413
  • ALogP: -1.98
  • ChEMBL Molecule:
More Chemistry
2-(6-amino-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol | 9-beta-d-arabinofuranosyl-9h-purin-6-amine | 9-beta-d-arabinofuranosyladenine | 9-beta-d-arabinofuranosyl-adenine | 9-β-d-arabinofuranosyl-9h-purin-6-amine | 9-β-d-arabinofuranosyladenine | adenine arabinoside | ara-a | araadenosine | arabinosyladenine | ci-673 | spongoadenosine | vidarabin | vidarabine | vira-a


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue